Main > PSYCHIATRY > Depression > Treatment > Methylphenidate (CNS Stimulant). > Enantiomer. > (S,S)-Enantiomer. > (L-Threo-Methylphenidate). > Patent > Literature > Claim 1: Dysphoria Treat. Method. > Adm.: L-Threo-Methylphenidate > Purity > 95%. Claim 2: Oral Adm. of > Sufficient Dose such that > First Pass Metabolism is Saturated > resulting in Therapeutically Effect > ive Amount of L-Threo MePhenidate > gets into Systemic Circulation for > desired Effect. Claim 3:

---

desired Effect. Claim 3:'s subsections
Systemic Adm.: IntraVenous Etc.

desired Effect. Claim 3:'s products
This section has no products